Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Hepatic resection of solitary HCC in the elderly: A unique disease in a growing population.

Zarour LR, Billingsley KG, Walker BS, Enestvedt CK, Orloff SL, Maynard E, Mayo SC.

Am J Surg. 2019 May;217(5):899-905. doi: 10.1016/j.amjsurg.2019.01.030. Epub 2019 Feb 1.

PMID:
30819401
2.

Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database.

Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL.

J Surg Res. 2019 Jun;238:198-206. doi: 10.1016/j.jss.2019.01.039. Epub 2019 Feb 14.

PMID:
30772678
3.

Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center.

Walcott-Sapp S, Naugler S, Lim JY, Wagner J, Orloff SL, Farsad K, Kolbeck KJ, Kaufman J, Maynard E, Enestvedt CK, Mayo SC, Billingsley KG.

J Gastrointest Oncol. 2018 Dec;9(6):1074-1083. doi: 10.21037/jgo.2018.08.11.

4.

Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.

Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, Parappilly MS, Roh-Johnson M, Goodman JR, Olson B, Schmidt M, Swain JR, Davies PS, Shasthri V, Iizuka S, Flynn P, Watson S, Korkola J, Courtneidge SA, Fischer JM, Jaboin J, Billingsley KG, Lopez CD, Burchard J, Gray J, Coussens LM, Sheppard BC, Wong MH.

Sci Adv. 2018 Sep 12;4(9):eaat7828. doi: 10.1126/sciadv.aat7828. eCollection 2018 Sep.

5.

Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.

Lu E, Perlewitz KS, Hayden JB, Hung AY, Doung YC, Davis LE, Mansoor A, Vetto JT, Billingsley KG, Kaempf A, Park B, Ryan CW.

Ann Surg Oncol. 2018 Apr;25(4):920-927. doi: 10.1245/s10434-018-6346-4. Epub 2018 Jan 31.

PMID:
29388122
6.

Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713.

Leichman CG, McDonough SL, Smalley SR, Billingsley KG, Lenz HJ, Beldner MA, Hezel AF, Velasco MR, Guthrie KA, Blanke CD, Hochster HS.

Clin Colorectal Cancer. 2018 Mar;17(1):e121-e125. doi: 10.1016/j.clcc.2017.10.008. Epub 2017 Oct 24.

7.

Preoperative optimization for major hepatic resection.

Walcott-Sapp S, Billingsley KG.

Langenbecks Arch Surg. 2018 Feb;403(1):23-35. doi: 10.1007/s00423-017-1638-x. Epub 2017 Nov 18. Review.

PMID:
29150719
8.

Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.

Zarour LR, Anand S, Billingsley KG, Bisson WH, Cercek A, Clarke MF, Coussens LM, Gast CE, Geltzeiler CB, Hansen L, Kelley KA, Lopez CD, Rana SR, Ruhl R, Tsikitis VL, Vaccaro GM, Wong MH, Mayo SC.

Cell Mol Gastroenterol Hepatol. 2017 Jan 20;3(2):163-173. doi: 10.1016/j.jcmgh.2017.01.006. eCollection 2017 Mar. Review.

9.

Nomogram for Predicting Overall Survival and Salvage Abdominoperineal Resection for Patients with Anal Cancer.

Tsikitis VL, Lu KC, Kim JS, Billingsley KG, Thomas CR Jr, Herzig DO.

Dis Colon Rectum. 2016 Jan;59(1):1-7.

PMID:
26651105
10.

Modern technical approaches in resectional hepatic surgery.

Michalski CW, Billingsley KG.

Surg Oncol Clin N Am. 2015 Jan;24(1):57-72. doi: 10.1016/j.soc.2014.09.007. Epub 2014 Nov 8. Review.

PMID:
25444469
11.

Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base.

Geltzeiler CB, Nabavizadeh N, Kim J, Lu KC, Billingsley KG, Thomas CR, Herzig DO, Tsikitis VL.

Ann Surg Oncol. 2014 Oct;21(11):3616-20. doi: 10.1245/s10434-014-3849-5. Epub 2014 Jun 20.

PMID:
24943237
12.

The international normalized ratio overestimates coagulopathy in patients after major hepatectomy.

Louis SG, Barton JS, Riha GM, Orloff SL, Sheppard BC, Pommier RF, Underwood SJ, Differding JA, Schreiber MA, Billingsley KG.

Am J Surg. 2014 May;207(5):723-7; discussion 727. doi: 10.1016/j.amjsurg.2013.12.021. Epub 2014 Mar 12.

PMID:
24791634
13.

Bile duct involvement portends poor prognosis in resected gallbladder carcinoma.

Eil R, Hansen PD, Cassera M, Orloff SL, Sheppard BC, Diggs B, Billingsley KG.

Gastrointest Cancer Res. 2013 Jul;6(4):101-5.

14.

Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Gur I, Diggs BS, Wagner JA, Vaccaro GM, Lopez CD, Sheppard BC, Orloff SL, Billingsley KG.

J Gastrointest Surg. 2013 Dec;17(12):2133-42. doi: 10.1007/s11605-013-2295-1. Epub 2013 Oct 4.

PMID:
24091909
15.

Coagulopathy after a liver resection: is it over diagnosed and over treated?

Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG.

HPB (Oxford). 2013 Nov;15(11):865-71. doi: 10.1111/hpb.12051. Epub 2013 Jan 29.

16.

Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.

Hessman CJ, Bubbers EJ, Billingsley KG, Herzig DO, Wong MH.

Am J Surg. 2012 May;203(5):649-653. doi: 10.1016/j.amjsurg.2012.01.003. Epub 2012 Mar 9.

17.

Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy.

Massimino KP, Kolbeck KJ, Enestvedt CK, Orloff S, Billingsley KG.

HPB (Oxford). 2012 Jan;14(1):14-9. doi: 10.1111/j.1477-2574.2011.00402.x. Epub 2011 Nov 13.

18.

S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.

Leichman LP, Goldman BH, Bohanes PO, Lenz HJ, Thomas CR, Billingsley KG, Corless CL, Iqbal S, Gold PJ, Benedetti JK, Danenberg KD, Blanke CD.

J Clin Oncol. 2011 Dec 1;29(34):4555-60. doi: 10.1200/JCO.2011.36.7490. Epub 2011 Oct 24.

19.

Predicting malignant intraductal papillary mucinous neoplasm: a single-center review.

Cone MM, Rea JD, Diggs BS, Douthit MA, Billingsley KG, Sheppard BC.

Am J Surg. 2011 May;201(5):575-9. doi: 10.1016/j.amjsurg.2011.01.003.

PMID:
21545902
20.

Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.

Hammill CW, Billingsley KG, Cassera MA, Wolf RF, Ujiki MB, Hansen PD.

Ann Surg Oncol. 2011 Jul;18(7):1947-54. doi: 10.1245/s10434-010-1535-9. Epub 2011 Mar 12.

PMID:
21399885
21.

Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasm.

Cone MM, Rea JD, Diggs BS, Billingsley KG, Sheppard BC.

HPB (Oxford). 2011 Feb;13(2):112-6. doi: 10.1111/j.1477-2574.2010.00254.x. Epub 2010 Dec 22.

22.

Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors.

Ellis MC, Cassera MA, Vetto JT, Orloff SL, Hansen PD, Billingsley KG.

HPB (Oxford). 2011 Jan;13(1):59-63. doi: 10.1111/j.1477-2574.2010.00242.x. Epub 2010 Dec 3.

24.

Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.

Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG.

Cancer. 2010 Jun 15;116(12):2932-40. doi: 10.1002/cncr.25082.

25.

Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy.

Lee DY, Mitchell EL, Jones MA, Landry GJ, Liem TK, Sheppard BC, Billingsley KG, Moneta GL.

J Vasc Surg. 2010 Mar;51(3):662-6. doi: 10.1016/j.jvs.2009.09.025. Epub 2010 Jan 18.

26.

Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?

Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG.

J Am Coll Surg. 2009 Jan;208(1):87-95. doi: 10.1016/j.jamcollsurg.2008.10.014.

PMID:
19228509
27.

Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).

Whitehead RP, Rankin C, Hoff PM, Gold PJ, Billingsley KG, Chapman RA, Wong L, Ward JH, Abbruzzese JL, Blanke CD.

Invest New Drugs. 2009 Oct;27(5):469-75. doi: 10.1007/s10637-008-9190-8. Epub 2008 Oct 22.

28.

Image of the month. Retrorectal cystic hamartoma (tailgut cyst).

Mayo SC, Huang H, Dobos N, Billingsley KG.

Arch Surg. 2008 Oct;143(10):1017, 1018. doi: 10.1001/archsurg.143.10.1017. No abstract available.

PMID:
18936384
29.

Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection?

Billingsley KG, Morris AM, Green P, Dominitz JA, Matthews B, Dobie SA, Barlow W, Baldwin LM.

J Am Coll Surg. 2008 Jun;206(6):1167-77. doi: 10.1016/j.jamcollsurg.2007.12.042. Epub 2008 Apr 14.

30.

Residual treatment disparities after oncology referral for rectal cancer.

Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD.

J Natl Cancer Inst. 2008 May 21;100(10):738-44. doi: 10.1093/jnci/djn145. Epub 2008 May 13.

31.

Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era?

Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA, Shipley DK, Sheppard BC, Billingsley KG.

J Gastrointest Surg. 2008 Jul;12(7):1177-84. doi: 10.1007/s11605-008-0514-y. Epub 2008 May 10.

PMID:
18470572
32.

Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship.

Billingsley KG, Morris AM, Dominitz JA, Matthews B, Dobie S, Barlow W, Wright GE, Baldwin LM.

Arch Surg. 2007 Jan;142(1):23-31; discussion 32.

PMID:
17224497
33.

Reoperation as a quality indicator in colorectal surgery: a population-based analysis.

Morris AM, Baldwin LM, Matthews B, Dominitz JA, Barlow WE, Dobie SA, Billingsley KG.

Ann Surg. 2007 Jan;245(1):73-9.

34.

Outcome following surgical therapy for gastrointestinal stromal tumors.

Gupta M, Sheppard BC, Corless CL, MacDonell KR, Blanke CD, Billingsley KG.

J Gastrointest Surg. 2006 Sep-Oct;10(8):1099-105.

PMID:
16966028
35.

Complications and antireflux medication use after antireflux surgery.

Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA.

Clin Gastroenterol Hepatol. 2006 Mar;4(3):299-305.

PMID:
16527692
36.

Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer.

Mauchley DC, Lynge DC, Langdale LA, Stelzner MG, Mock CN, Billingsley KG.

Am J Surg. 2005 May;189(5):512-7; discussion 517.

PMID:
15862487
37.

Uncommon anal neoplasms.

Billingsley KG, Stern LE, Lowy AM, Kahlenberg MS, Thomas CR Jr.

Surg Oncol Clin N Am. 2004 Apr;13(2):375-88. Review.

PMID:
15137963
38.

Care of patients after esophagectomy.

Mackenzie DJ, Popplewell PK, Billingsley KG.

Crit Care Nurse. 2004 Feb;24(1):16-29; quiz 30-1. Review. No abstract available.

39.

Racial disparities in rectal cancer treatment: a population-based analysis.

Morris AM, Billingsley KG, Baxter NN, Baldwin LM.

Arch Surg. 2004 Feb;139(2):151-5; discussion 156.

PMID:
14769572
40.

Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program.

Billingsley KG, Hur K, Henderson WG, Daley J, Khuri SF, Bell RH Jr.

J Gastrointest Surg. 2003 May-Jun;7(4):484-491. doi: 10.1016/S1091-255X(03)00067-2.

PMID:
12763405
41.

The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer.

Barton JB, Langdale LA, Cummins JS, Stelzner M, Lynge DC, Mock CN, Nason KS, Billingsley KG.

Am J Surg. 2002 May;183(5):499-503.

PMID:
12034380
42.

The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results.

Billingsley KG, Schwartz DL, Lentz S, Vallières E, Montgomery RB, Schubach W, Penson D, Yueh B, Chansky H, Zink C, Parayno D, Starkebaum G.

Telemed J E Health. 2002 Spring;8(1):123-30.

PMID:
12020412
43.

Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia.

Dominitz JA, Maynard C, Billingsley KG, Boyko EJ.

Med Care. 2002 Jan;40(1 Suppl):I14-26.

PMID:
11789626
44.
45.

Acute presentation of transverse colon injury following percutaneous endoscopic gastrostomy tube placement: case report and review of current management.

Maccabee DL, Dominitz JA, Lee SW, Billingsley KG.

Surg Endosc. 2000 Mar;14(3):296. Epub 2000 Feb 12.

PMID:
10854520
46.

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, Brennan MF.

Ann Surg. 1999 May;229(5):602-10; discussion 610-2.

47.

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.

Billingsley KG, Lewis JJ, Leung DH, Casper ES, Woodruff JM, Brennan MF.

Cancer. 1999 Jan 15;85(2):389-95.

PMID:
10023707
48.

Segment-oriented hepatic resection in the management of malignant neoplasms of the liver.

Billingsley KG, Jarnagin WR, Fong Y, Blumgart LH.

J Am Coll Surg. 1998 Nov;187(5):471-81.

PMID:
9809562
49.

Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexia.

Billingsley KG, Fraker DL, Strassmann G, Loeser C, Fliot HM, Alexander HR.

Ann Surg Oncol. 1996 Jan;3(1):29-35.

PMID:
8770299
50.

Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor.

Block MI, Fraker DL, Strassmann G, Billingsley KG, Arnold WS, Perlis C, Alexander HR.

Int J Cancer. 1995 Oct 9;63(2):245-9.

PMID:
7591212

Supplemental Content

Loading ...
Support Center